de Coaña, Y. P., Wolodarski, M., Poschke, I., Yoshimoto, Y., Yang, Y., Nyström, M., . . . Kiessling, R. (2017). Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma. Oncotarget.

de Coaña, Yago Pico, et al. "Ipilimumab Treatment Decreases Monocytic MDSCs and Increases CD8 Effector Memory T Cells in Long-term Survivors With Advanced Melanoma." Oncotarget 2017.

de Coaña, Yago Pico, et al. "Ipilimumab Treatment Decreases Monocytic MDSCs and Increases CD8 Effector Memory T Cells in Long-term Survivors With Advanced Melanoma." Oncotarget 2017.